Solvent-free cyclodextrin nanosponges complexes for increasing the bioavailability
Recently the Francesco Trotta’s group of the University of Turin (Italy) has finalized and published the preliminar results that he
Category: CD derivatives
A cyclodextrin-based turn-off fluorescent probe for naked-eye detection of copper ions in aqueous solution
A novel fluorescent probe L consisting of β-Cyclodextrin (β-CD) and thiosemicarbazide moieties was designed for copper ions detection. Apparent fluorescence quenching of
Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications – Review
This review discusses the structure, properties, and preparation methods of SBE-β-CD-based inclusion complexes (ICs). Furthermore, we discuss here the preparation
Charged Hyper-branched Cyclodextrin-based polymers for different biological applications
Authors: Monfared, Y.K and Matencio, A. University of Turin. Recently, prof. Francesco Trotta group of the University of Turin has
SBECD polymer to prolong the antibacterial activity
SBECD polymer was prepared by crosslinking with 1,6-hexamethylene diisocyanate. Iin vitro studies were conducted on two Escherichia coli strains that differed in
Preparation of β-cyclodextrin-based dimers with selectively methylated rims and their use for solubilization of tetracene
A series of β-cyclodextrin dimers selectively permethylated on the primary or secondary rim with two different types of spacers have
May a novel alfa-cyclodextrin derivative be applied effectively to capture atmospheric methane?
Researchers at the University of Copenhagen’s Faculty of Science received a research grant to find out. Methane gas is 86
Mechanochemical synthesis of reticular β-cyclodextrin polyurethanes for the decontamination of phenolic micropollutants
Cyclodextrin-based porous polymers have become a kind of promising adsorbents for the remediation of wastewater by virtue of their sustainability
Nature.com: HPBCD treatment improves learning and executive function in Alzheimer model mice
Earlier we have reported on a patent appication related to HPBCD treatment in Alzheimer’s disease based on the invention of
First Patient Enrolled in Phase 1 Study of Midatech’s Panobinostat / HPBCD (MTX-110) for Recurrent Glioblastoma
Midatech Pharma PLC, an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announced on 14 November